awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36792338-FA8D5BA7-5C3B-4F74-8667-F9150DB9AA17
Q36792338-FA8D5BA7-5C3B-4F74-8667-F9150DB9AA17
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36792338-FA8D5BA7-5C3B-4F74-8667-F9150DB9AA17
Sustained Virologic Response at 24 Weeks after the End of Treatment Is a Better Predictor for Treatment Outcome in Real-World HCV-Infected Patients Treated by HCV NS3/4A Protease Inhibitors with Peginterferon plus Ribavirin
P2860
Q36792338-FA8D5BA7-5C3B-4F74-8667-F9150DB9AA17
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36792338-FA8D5BA7-5C3B-4F74-8667-F9150DB9AA17
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
462b2490a3dc07da6fb54041f9cedbd0f7449271
P2860
Sustained Virological Response after 8-Week Treatment of Simeprevir with Peginterferon α-2a plus Ribavirin in a Japanese Female with Hepatitis C Virus Genotype 1b and IL28B Minor Genotype.